Loading...
•
Dec 31, 2024
NeueHealth Q4 2024 Earnings Report
NeueHealth reported its Q4 2024 results, returning to profitability with net income of $2.52 million and delivering positive adjusted EBITDA.
Key Takeaways
NeueHealth achieved strong fourth-quarter results, with $232.64 million in revenue and net income of $2.52 million. The company reported positive adjusted EBITDA for the fourth consecutive quarter, highlighting the success of its value-driven, consumer-centric care model.
Q4 2024 revenue was $232,638,000, showing a decrease from the prior year but supported by diversified segments.
Net income for the quarter reached $2,523,000, reversing a significant loss in Q4 2023.
Adjusted EBITDA came in at $5,482,000, compared to negative $10,356,000 in Q4 2023.
The company served 360,000 value-based consumers and 123,000 enablement services lives as of December 31, 2024.
NeueHealth
NeueHealth
Forward Guidance
NeueHealth did not provide explicit financial guidance but emphasized strategic growth in 2025, focusing on expanding consumer reach and payor-provider relationships.
Positive Outlook
- Continued focus on expanding consumer base in new and existing markets.
- Building on strong relationships with payors and providers.
- Sustained positive adjusted EBITDA for four consecutive quarters.
- Solid foundation for continued financial performance in 2025.
- Focus on delivering a seamless, coordinated care experience.
Challenges Ahead
- Revenue decline in Q4 compared to the prior year.
- Operating loss of $29.4 million in Q4 2024.
- High medical and operating costs impacting profitability.
- Potential headwinds from industry and regulatory changes.
- Uncertainty regarding the upcoming merger and future operational structure.